NASDAQ:FATE | Free Cash Flow | FATE THERAPEUTICS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30-$23.4M
2026-03-31-$30.82M$239,000.00-$31.06M
2025-12-31-$23.31M$1.19M-$24.51M
2025-03-31-$33.81M$1.2M-$35.01M
2024-12-31-$27.8M$98,000.00-$27.9M
2024-03-31-$33.35M$86,000.00-$33.44M
2023-12-31-$36.64M$181,000.00-$36.82M
2023-03-31-$28.86M$3.21M-$32.07M
2022-12-31-$75.39M$6.68M-$82.07M
2022-03-31-$64.61M$10.08M-$74.7M
2021-12-31-$70.29M$18.37M-$88.66M
2021-03-31-$27.1M$3.98M-$31.08M
2020-12-31-$20.66M$2.27M-$22.94M
2020-03-31-$26.67M$1.07M-$27.74M
2019-12-31-$25.54M$2.59M-$28.13M
2019-03-31-$17.49M$1.75M-$19.24M
2018-12-31-$11.02M$1.12M-$12.14M
2018-03-31-$12.55M$184,000.00-$12.74M
2017-12-31-$10.72M$797,000.00-$11.52M
2017-03-31-$7.46M$155,000.00-$7.61M
2016-12-31-$7.55M$40,000.00-$7.59M
2016-03-31-$7.25M$178,000.00-$7.43M
2015-12-31-$6.97M$178,000.00-$7.15M
2015-03-31-$6.38M$452,000.00-$6.83M
2014-12-31-$6.15M$271,000.00-$6.43M
2014-03-31-$5.26M$398,000.00-$5.65M
2013-12-31-$4.58M$150,000.00-$4.73M
2013-03-31-$3.93M$7,000.00-$3.94M
2012-12-31-$3.39M$295,000.00-$3.69M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$106.08M$5.95M-$112.04M
2024-12-31-$122.87M$730,000.00-$123.6M
2023-12-31-$132.26M$6.15M-$138.42M
2022-12-31-$248.21M$35.57M-$283.77M
2021-12-31-$162.87M$50.7M-$213.57M
2020-12-31-$39.23M$4.93M-$44.16M
2019-12-31-$83.18M$7.4M-$90.57M
2018-12-31-$38.65M$2.3M-$40.95M
2017-12-31-$36.82M$1.73M-$38.54M
2016-12-31-$29.82M$457,000.00-$30.28M
2015-12-31-$18.4M$1.5M-$19.9M
2014-12-31-$22.42M$882,000.00-$23.3M
2013-12-31-$15.37M$244,000.00-$15.62M
2012-12-31-$13.27M$709,000.00-$13.98M
2011-12-31-$12.15M$2,000.00-$12.15M